Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Alcon (ALC : NYSE)
 
 • Company Description   
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.

Number of Employees: 25,599

 
 • Price / Volume Information   
Yesterday's Closing Price: $87.78 Daily Weekly Monthly
20 Day Moving Average: 1,466,860 shares
Shares Outstanding: 493.24 (millions)
Market Capitalization: $43,296.96 (millions)
Beta: 0.95
52 Week High: $101.10
52 Week Low: $80.48
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.98% -4.49%
12 Week 0.90% -15.35%
Year To Date 3.40% -3.14%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
Rue Louis-d`Affry 6
-
Fribourg,V8 1701
CHE		 ph: 817-293-0450
fax: 817-916-2652		 investor.relations@alcon.com http://www.alcon.com
 
 • General Corporate Information   
Officers
Dieter P. Spalti - Chief Executive Officer
Thomas H. Glanzmann - Chairman
Scott H. Maw - Director
Karen J. May - Director
Ines Poschel - Director

Peer Information
Alcon (ABMD)
Alcon (DMDS)
Alcon (CPWY.)
Alcon (EQUR)
Alcon (ECIA)
Alcon (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: H01301128
SIC: 3851
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/19/25
Share - Related Items
Shares Outstanding: 493.24
Most Recent Split Date: (:1)
Beta: 0.95
Market Capitalization: $43,296.96 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.80 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $3.11 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 12.59% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/19/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 28.26
Trailing 12 Months: 29.26
PEG Ratio: 2.24
Price Ratios
Price/Book: 1.97
Price/Cash Flow: 15.80
Price / Sales: 4.36
EPS Growth
vs. Year Ago Period: -6.41%
vs. Previous Quarter: 1.39%
Sales Growth
vs. Year Ago Period: 0.57%
vs. Previous Quarter: -1.16%
ROE
06/30/25 - -
03/31/25 - 6.95
12/31/24 - 7.15
ROA
06/30/25 - -
03/31/25 - 4.92
12/31/24 - 5.05
Current Ratio
06/30/25 - -
03/31/25 - 2.70
12/31/24 - 2.77
Quick Ratio
06/30/25 - -
03/31/25 - 1.66
12/31/24 - 1.77
Operating Margin
06/30/25 - -
03/31/25 - 15.04
12/31/24 - 15.29
Net Margin
06/30/25 - -
03/31/25 - 11.28
12/31/24 - 10.27
Pre-Tax Margin
06/30/25 - -
03/31/25 - 13.45
12/31/24 - 12.67
Book Value
06/30/25 - -
03/31/25 - 44.64
12/31/24 - 43.70
Inventory Turnover
06/30/25 - -
03/31/25 - 1.89
12/31/24 - 1.89
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.21
12/31/24 - 0.21
Debt-to-Capital
06/30/25 - -
03/31/25 - 17.27
12/31/24 - 17.39
 

Powered by Zacks Investment Research ©